Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of <i>Clostridium difficile</i> Infection Associated with Antibacterial Drug Exposure

Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of <i>Clostridium difficile</i> Infection Associated with Antibacterial Drug Exposure

Antibacterial drug exposure (ADE) is a well-known potential risk factor for <i>Clostridium difficile</i> infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI risk associated with ADE, we r...

Full description

Bibliographic Details
Main Authors: Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing Liu
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Antibiotics
Subjects:
<i>Clostridium difficile</i> infection
antibacterial drug
FDA Adverse Event Reporting System
pharmacovigilance
disproportionality analysis
adverse reaction
Online Access:https://www.mdpi.com/2079-6382/12/7/1109

Internet

https://www.mdpi.com/2079-6382/12/7/1109

Similar Items